Novo Nordisk launches multi-month subscriptions for Wegovy obesity drugs as it tries to catch up with Eli Lilly

6 months ago 121

Wegovy semaglutide tablets.

Michael Siluk | Universal Images Group | Getty Images

Novo Nordisk

Read Entire Article
  1. Homepage
  2. Finance
  3. Novo Nordisk launches multi-month subscriptions for Wegovy obesity drugs as it tries to catch up with Eli Lilly

Related

Goldman Sachs CEO succession planning faces one big problem

Goldman Sachs CEO succession planning faces one big problem

6 hours ago 7
Ford CEO says it's 'too late' for Europe to fend off Chinese automakers, but not U.S.

Ford CEO says it's 'too late' for Europe to fend off Chinese...

7 hours ago 6
Disney laying off around 300 employees in latest cuts under new CEO Josh D'Amaro

Disney laying off around 300 employees in latest cuts under ...

9 hours ago 6
RIGHT SIDEBAR TOP AD

Trending

1. kai trump
2. diego campillo
3. jj peterka
4. cory booker
5. padres score
6. manny machado
7. chad lowe
8. michael king
9. bill murray
10. navy fighter jets

Popular

The Solar System chose fire over ice from the very beginning

The Solar System chose fire over ice from the very beginning...

6 days ago 40
The LHC just ruled out another hiding place for quantum black holes

The LHC just ruled out another hiding place for quantum blac...

6 days ago 39
China’s Xi visits US as Trump bets on stabilising global relations

China’s Xi visits US as Trump bets on stabilising global rel...

6 days ago 38
The Ovary Is Surprisingly Active After Menopause. Scientists Are Trying to Figure Out Why

The Ovary Is Surprisingly Active After Menopause. Scientists...

5 days ago 37
"I'm Still Alive, I'm Still Here": Actors Whose Performances In Movies Were So Reviled, It Basically Ended Their Careers

"I'm Still Alive, I'm Still Here": Actors Whose Performances...

6 days ago 35
RIGHT SIDEBAR BOTTOM AD
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions · Privacy Policy · DMCA · Cookie Policy · Advertise With Us ·

© Primetweets 2026. All rights are reserved